InvestorsHub Logo
Followers 32
Posts 1358
Boards Moderated 0
Alias Born 10/22/2013

Re: None

Tuesday, 11/08/2016 10:03:41 AM

Tuesday, November 08, 2016 10:03:41 AM

Post# of 17395
In reaction to the results of the EOP2 meeting, which the analyst praises as “better than we could have hoped for,” he reiterates a Buy rating on shares of AUPH with a $10 price target, which represents a 295% increase from current levels.

http://www.smarteranalyst.com/2016/11/07/h-c-wainwright-believes-aurinia-pharmaceuticals-inc-auph-wins-big-results-end-phase-2-meeting-fda/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News